Astigmatism, or nearsightedness, is a developing issue everywhere throughout the world.
There are presently twice the same number of people in the United States and Europe with this condition as there was previously.
In East Asia, 70 to 90 percent of adolescents and more young adults are myopic.
Through some estimates, about 2.5 billion of people around the world may be plagued by myopia by 2020.
Eye glasses and contact lenses are simple solutions; a more perpetual one is corneal refractive surgery.
But, even as corrective surgery has a high cost, it is an invasive approach, and can give rise to more surgical complications, and in rare instances, permanent vision loss.
Likewise, laser-assisted vision correction procedures similar to laser in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) still utilize ablative science, which will disperse and lead to weakness of the cornea.
Noninvasive Technique of Myopia
Columbia Engineering specialist Sinisa Vukelic has built up another non-invasive procedure to accomplish the correct vision that demonstrates amazing promise.
His approach uses a femtosecond oscillator, a ultrafast laser that conveys pulses of low energy repeatedly for specific and localized adjustment of the biochemical properties of corneal tissue.
The method, which changes the tissue’s macro geometry, is non-surgical and has less symptoms and limitations than those observable in refractive medical procedures.
For example, sufferers with thin corneas, dry eyes, and diverse anomalies can’t have refractive surgery.
The researchers consider this study to be the first to use this laser output treatment for noninvasive alternative treatment of corneal curvature or treatment of other medical problems.
His approach uses a femtosecond oscillator to change biochemical and biomechanical properties of collagenous tissue without causing cell harm and tissue disturbance.
The procedure enables for adequate energy to result in a low-density plasma within the set focal quantity however, it does not deliver adequate energy to cause injury to the tissue within the treatment area.
The focal component to this approach is that the acceptance of low-density plasma realizes the ionization of water molecules inside the cornea.
This ionization creates a reactive oxygen species, a type of unstable molecule that includes oxygen and that readily reacts with other molecules in a cell, which in turn interacts with the collagen fibrils to create chemical bonds, or crosslinks.
The particular presentation of these crosslinks initiates changes in the mechanical properties of the treated corneal tissue.
At the point when this system is utilized in corneal tissue, the crosslinking adjusts the collagen properties in the areas, and this inevitably brings about changes in the aggregate macrostructure of the cornea.
The medicine ionizes the molecules inside the cornea while stopping optical breakdown of the corneal tissue. Given that the procedure is photochemical, it doesn’t upset tissue and the incited changes remain stable.
The specialists commented that what is amazing is that this strategy is simply not restricted to ocular media, but it might be utilized on various collagen-rich tissues.
They feel that this non-invasive strategy has the abilities to manage or reestablish collagenous tissue without creating tissue damage.